Cargando…
SOCS7-Derived BC-Box Motif Peptide Mediated Cholinergic Differentiation of Human Adipose-Derived Mesenchymal Stem Cells
Adipose-derived mesenchymal stem cells (ADMSCs) are a type of pluripotent somatic stem cells that differentiate into various cell types such as osteoblast, chondrocyte, and neuronal cells. ADMSCs as donor cells are used to produce regenerative medicines at hospitals and clinics. However, it has not...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917589/ https://www.ncbi.nlm.nih.gov/pubmed/36769102 http://dx.doi.org/10.3390/ijms24032786 |
_version_ | 1784886403657629696 |
---|---|
author | Kanno, Hiroshi Matsumoto, Shutaro Yoshizumi, Tetsuya Nakahara, Kimihiro Shinonaga, Masamichi Kubo, Atsuhiko Fujii, Satoshi Ishizuka, Yasuyuki Tanaka, Masaki Ichihashi, Masamitsu Murata, Hidetoshi |
author_facet | Kanno, Hiroshi Matsumoto, Shutaro Yoshizumi, Tetsuya Nakahara, Kimihiro Shinonaga, Masamichi Kubo, Atsuhiko Fujii, Satoshi Ishizuka, Yasuyuki Tanaka, Masaki Ichihashi, Masamitsu Murata, Hidetoshi |
author_sort | Kanno, Hiroshi |
collection | PubMed |
description | Adipose-derived mesenchymal stem cells (ADMSCs) are a type of pluripotent somatic stem cells that differentiate into various cell types such as osteoblast, chondrocyte, and neuronal cells. ADMSCs as donor cells are used to produce regenerative medicines at hospitals and clinics. However, it has not been reported that ADMSCs were differentiated to a specific type of neuron with a peptide. Here, we report that ADMSCs differentiate to the cholinergic phenotype of neurons by the SOCS7-derived BC-box motif peptide. At operations for patients with neurological disorders, a small amount of subcutaneous fat was obtained. Two weeks later, adipose-derived mesenchymal stem cells (ADMSCs) were isolated and cultured for a further 1 to 2 weeks. Flow cytometry analysis for characterization of ADMSCs was performed with CD73, CD90, and CD105 as positive markers, and CD14, CD31, and CD56 as negative markers. The results showed that cultured cells were compatible with ADMSCs. Immunocytochemical studies showed naïve ADMSCs immunopositive for p75NTR, RET, nestin, keratin, neurofilament-M, and smooth muscle actin. ADMSCs were suggested to be pluripotent stem cells. A peptide corresponding to the amino-acid sequence of BC-box motif derived from SOCS7 protein was added to the medium at a concentration of 2 μM. Three days later, immunocytochemistry analysis, Western blot analysis, ubiquitination assay, and electrophysiological analysis with patch cramp were performed. Immunostaining revealed the expression of neurofilament H (NFH), choline acetyltransferase (ChAT), and tyrosine hydroxylase (TH). In addition, Western blot analysis showed an increase in the expression of NFH, ChAT, and TH, and the expression of ChAT was more distinct than TH. Immunoprecipitation with JAK2 showed an increase in the expression of ubiquitin. Electrophysiological analysis showed a large holding potential at the recorded cells through path electrodes. The BC-box motif peptide derived from SOCS7 promoted the cholinergic differentiation of ADMSCs. This novel method will contribute to research as well as regenerative medicine for cholinergic neuron diseases. |
format | Online Article Text |
id | pubmed-9917589 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-99175892023-02-11 SOCS7-Derived BC-Box Motif Peptide Mediated Cholinergic Differentiation of Human Adipose-Derived Mesenchymal Stem Cells Kanno, Hiroshi Matsumoto, Shutaro Yoshizumi, Tetsuya Nakahara, Kimihiro Shinonaga, Masamichi Kubo, Atsuhiko Fujii, Satoshi Ishizuka, Yasuyuki Tanaka, Masaki Ichihashi, Masamitsu Murata, Hidetoshi Int J Mol Sci Article Adipose-derived mesenchymal stem cells (ADMSCs) are a type of pluripotent somatic stem cells that differentiate into various cell types such as osteoblast, chondrocyte, and neuronal cells. ADMSCs as donor cells are used to produce regenerative medicines at hospitals and clinics. However, it has not been reported that ADMSCs were differentiated to a specific type of neuron with a peptide. Here, we report that ADMSCs differentiate to the cholinergic phenotype of neurons by the SOCS7-derived BC-box motif peptide. At operations for patients with neurological disorders, a small amount of subcutaneous fat was obtained. Two weeks later, adipose-derived mesenchymal stem cells (ADMSCs) were isolated and cultured for a further 1 to 2 weeks. Flow cytometry analysis for characterization of ADMSCs was performed with CD73, CD90, and CD105 as positive markers, and CD14, CD31, and CD56 as negative markers. The results showed that cultured cells were compatible with ADMSCs. Immunocytochemical studies showed naïve ADMSCs immunopositive for p75NTR, RET, nestin, keratin, neurofilament-M, and smooth muscle actin. ADMSCs were suggested to be pluripotent stem cells. A peptide corresponding to the amino-acid sequence of BC-box motif derived from SOCS7 protein was added to the medium at a concentration of 2 μM. Three days later, immunocytochemistry analysis, Western blot analysis, ubiquitination assay, and electrophysiological analysis with patch cramp were performed. Immunostaining revealed the expression of neurofilament H (NFH), choline acetyltransferase (ChAT), and tyrosine hydroxylase (TH). In addition, Western blot analysis showed an increase in the expression of NFH, ChAT, and TH, and the expression of ChAT was more distinct than TH. Immunoprecipitation with JAK2 showed an increase in the expression of ubiquitin. Electrophysiological analysis showed a large holding potential at the recorded cells through path electrodes. The BC-box motif peptide derived from SOCS7 promoted the cholinergic differentiation of ADMSCs. This novel method will contribute to research as well as regenerative medicine for cholinergic neuron diseases. MDPI 2023-02-01 /pmc/articles/PMC9917589/ /pubmed/36769102 http://dx.doi.org/10.3390/ijms24032786 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Kanno, Hiroshi Matsumoto, Shutaro Yoshizumi, Tetsuya Nakahara, Kimihiro Shinonaga, Masamichi Kubo, Atsuhiko Fujii, Satoshi Ishizuka, Yasuyuki Tanaka, Masaki Ichihashi, Masamitsu Murata, Hidetoshi SOCS7-Derived BC-Box Motif Peptide Mediated Cholinergic Differentiation of Human Adipose-Derived Mesenchymal Stem Cells |
title | SOCS7-Derived BC-Box Motif Peptide Mediated Cholinergic Differentiation of Human Adipose-Derived Mesenchymal Stem Cells |
title_full | SOCS7-Derived BC-Box Motif Peptide Mediated Cholinergic Differentiation of Human Adipose-Derived Mesenchymal Stem Cells |
title_fullStr | SOCS7-Derived BC-Box Motif Peptide Mediated Cholinergic Differentiation of Human Adipose-Derived Mesenchymal Stem Cells |
title_full_unstemmed | SOCS7-Derived BC-Box Motif Peptide Mediated Cholinergic Differentiation of Human Adipose-Derived Mesenchymal Stem Cells |
title_short | SOCS7-Derived BC-Box Motif Peptide Mediated Cholinergic Differentiation of Human Adipose-Derived Mesenchymal Stem Cells |
title_sort | socs7-derived bc-box motif peptide mediated cholinergic differentiation of human adipose-derived mesenchymal stem cells |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917589/ https://www.ncbi.nlm.nih.gov/pubmed/36769102 http://dx.doi.org/10.3390/ijms24032786 |
work_keys_str_mv | AT kannohiroshi socs7derivedbcboxmotifpeptidemediatedcholinergicdifferentiationofhumanadiposederivedmesenchymalstemcells AT matsumotoshutaro socs7derivedbcboxmotifpeptidemediatedcholinergicdifferentiationofhumanadiposederivedmesenchymalstemcells AT yoshizumitetsuya socs7derivedbcboxmotifpeptidemediatedcholinergicdifferentiationofhumanadiposederivedmesenchymalstemcells AT nakaharakimihiro socs7derivedbcboxmotifpeptidemediatedcholinergicdifferentiationofhumanadiposederivedmesenchymalstemcells AT shinonagamasamichi socs7derivedbcboxmotifpeptidemediatedcholinergicdifferentiationofhumanadiposederivedmesenchymalstemcells AT kuboatsuhiko socs7derivedbcboxmotifpeptidemediatedcholinergicdifferentiationofhumanadiposederivedmesenchymalstemcells AT fujiisatoshi socs7derivedbcboxmotifpeptidemediatedcholinergicdifferentiationofhumanadiposederivedmesenchymalstemcells AT ishizukayasuyuki socs7derivedbcboxmotifpeptidemediatedcholinergicdifferentiationofhumanadiposederivedmesenchymalstemcells AT tanakamasaki socs7derivedbcboxmotifpeptidemediatedcholinergicdifferentiationofhumanadiposederivedmesenchymalstemcells AT ichihashimasamitsu socs7derivedbcboxmotifpeptidemediatedcholinergicdifferentiationofhumanadiposederivedmesenchymalstemcells AT muratahidetoshi socs7derivedbcboxmotifpeptidemediatedcholinergicdifferentiationofhumanadiposederivedmesenchymalstemcells |